普通外科
止血的管理和優化
抗纖溶藥物
Tranexamic acid demonstrates efficacy without increased risk for venous thromboembolic events in cranial neurosurgery: systematic review of the evidence and current applications in nontraumatic pathologies. (開啟新視窗)
來源: World Neurosurg 2024;183:29-40.
檢索: PubMed 38052364
DOI碼: 10.1016/j.wneu.2023.11.148
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (開啟新視窗)
來源: Cochrane Database Syst Rev 2011;(3):CD001886.
檢索: PubMed 21412876
DOI碼: 10.1002/14651858.CD001886.pub4
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. (開啟新視窗)
來源: BMJ 2012;344:e3054.
檢索: PubMed 22611164
Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. (開啟新視窗)
來源: Br J Surg 2013;100(10):1271-9.
檢索: PubMed 23839785
DOI碼: 10.1002/bjs.9193
Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. (開啟新視窗)
來源: JAMA Surg 2021;156(6):e210884.
檢索: PubMed 33851983
DOI碼: 10.1001/jamasurg.2021.0884
重組活化凝血因子VII(rFVIIa)
Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (開啟新視窗)
來源: Acta Anaesthesiol Scand 2012;56(5):636-44.
檢索: PubMed 22489992
DOI碼: 10.1111/j.1399-6576.2012.02688.x
凝血因子濃縮劑
Fibrinogen replacement therapy: a critical review of the literature. (開啟新視窗)
來源: Blood Transfus 2012;10(1):23-7.
檢索: PubMed 22153684
DOI碼: 10.2450/2011.0015-11
Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (開啟新視窗)
來源: Transfusion 2014;54(5):1389-405.
檢索: PubMed 24117955
DOI碼: 10.1111/trf.12431
利用血液粘彈性檢測辨別外科性出血或凝血病出血
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. (開啟新視窗)
來源: Eur J Anaesthesiol 2013;30(6):270-382.
檢索: PubMed 23656742
DOI碼: 10.1097/EJA.0b013e32835f4d5b